Stock Floating Above Moving Averages: Pfizer Inc. (NYSE:PFE)

Xavier Trudeau
Août 8, 2017

The fund owned 18,579 shares of the biopharmaceutical company's stock after buying an additional 1,250 shares during the period. In the last earnings report the EPS was $1.37 and is estimated to be $2.56 for the current year with 5,967,844,000 shares presently outstanding. The firm has a market cap of $198.82 billion, a PE ratio of 24.371 and a beta of 1.00. 12,460,212 shares of the company's stock were exchanged. About 171,294 shares traded. Banc of California Inc (NYSE:BANC) has risen 6.54% since August 7, 2016 and is uptrending. Checking in on some other technical levels, the 14-day RSI is now at 60.84.

Dimensional Fund Advisors Lp decreased its stake in Pfizer Inc (PFE) by 1.28% based on its latest 2016Q4 regulatory filing with the SEC. The value of the company's investment in Pfizer, Inc. went from $91,637,000 to $70,246,000 a change of $21,391,000 quarter over quarter. Sterling Investment Management holdings in Pfizer were valued $1,894,000 during the latest period. The shares were last seen trading 0.63% higher, taking the closing price at $33.64 on 8/4/2017. DIKER CHARLES M sold 58 shares worth $2,762.

Pfizer Inc (Pfizer) is a research-based global biopharmaceutical company. It has underperformed by 19.46% the S&P500.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Finally, Pure Financial Advisors Inc. boosted its position in Pfizer by 0.4% in the first quarter. (NYSE:PFE) has "Buy" rating given on Thursday, August 4 by Jefferies. About shares traded. Pfizer Inc. Moloney Securities Asset Management LLC purchased a new stake in shares of Pfizer during the fourth quarter valued at $809,000. EPS breaks down the profitability of the company on a single share basis.

Investors sentiment increased to 1.24 in Q4 2016. The stock rose 0.35% or $0.17 reaching $49.14. The total value of its holdings increased 3.3%. 69 funds opened positions while 92 raised stakes. Capstone Asset Management owns 190,117 shares for 0.18% of their portfolio. Pennsylvania-based Emerald Advisers Incorporated Pa has invested 0.55% in Gigamon Inc (NYSE:GIMO). Moreover, Lagoda Investment Lp has 0.01% invested in Pfizer Inc. 920,599 were reported by National Bank & Trust Of America Corporation De. The stock has "Mkt Perform" rating by FBR Capital on Friday, July 1. Los Angeles & Equity reported 4,585 shares. Over the last three months, the shares of the company have changed 0.48% and performed 4.83% over the last six months. Blue Chip Prtn holds 0.84% or 65,852 shares in its portfolio. Hightower Advisors Lc invested 0% in Gigamon Inc (NYSE:GIMO). Fincl Bank Of Montreal Can holds 0% or 15,344 shares. Private Gru owns 741,678 shares. Evermay Wealth Management Limited Liability Com accumulated 61,234 shares or 0.97% of the stock. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and ten have given a buy rating to the company. Needham maintained the stock with "Buy" rating in Friday, April 28 report. FBR Capital maintained Banc of California Inc (NYSE:BANC) rating on Thursday, October 20. Jefferies downgraded Pfizer Inc. The firm has "Buy" rating by Jefferies given on Tuesday, June 14.

On May 16 the company was set at "Sell" in a report from Citigroup which was a cut from the previous "Buy" rating. The stock of Gigamon Inc (NYSE:GIMO) has "Neutral" rating given on Friday, July 28 by DA Davidson. The firm has "Neutral" rating by SunTrust given on Wednesday, November 25. Wells Fargo upgraded the stock to "Outperform" rating in Tuesday, April 11 report.

Pfizer, Inc. (NYSE:PFE) was upgraded by equities research analysts at BidaskClub from a "strong sell" rating to a "sell" rating in a note issued to investors on Saturday. Therefore 30% are positive. Pfizer had 51 analyst reports since July 29, 2015 according to SRatingsIntel. The company was maintained on Friday, March 24 by Societe Generale.

A number of research analysts have recently commented on PFE shares.

07/20/2017 - Pfizer, Inc. was downgraded to " by analysts at Credit Suisse. (PFE) opened at 33.64 on Monday. Barclays PLC reissued a "buy" rating and set a $38.00 target price on shares of Pfizer in a report on Wednesday, May 3rd. (NYSE:PFE). Rmsincerbeaux Capital Limited Liability Corp stated it has 71,900 shares or 2.21% of all its holdings. The firm has "Hold" rating given on Wednesday, November 2 by Argus Research. Svenska Handelsbanken AB publ's holdings in Pfizer were worth $636,000 as of its most recent filing with the SEC. (NYSE:PFE) news were published by: Benzinga.com which released: "Earnings Preview: Pharma Giant Pfizer Reports Q2 Results Tomorrow Morning" on July 31, 2017, also Seekingalpha.com with their article: "Pfizer - Investors Remain Skeptical About Growth And The Pipeline" published on August 02, 2017, Businessinsider.com published: "Pfizer misses earnings on disappointing drug sales" on August 01, 2017.

D'autres rapports CampDesrEcrues

Discuter de cet article

SUIVRE NOTRE JOURNAL